Skip to main content

InDevR Webinar: Highly Multiplexed, 30-minute VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

edtenent_headshot.jpg
June 7, 2022

InDevR Webinar: Highly Multiplexed, 30-minute VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

8th of June at 14:00-15:00 CET.

Brief Abstract: This presentation will highlight the VaxArray Pneumococcal Assay, a newly available standardized, off-the-shelf kit for simultaneous identity, quantity, and stability testing of 23 vaccine-relevant pneumococcal serotypes. Following an introduction to the VaxArray Platform and intended applications of the assay, we will present key analytical performance metrics generated during assay validation for a wide variety of native polysaccharides, CRM197-conjugates, and final vaccine materials including both pneumococcal polysaccharide and pneumococcal conjugate vaccines to highlight the assay’s potential to streamline pneumococcal vaccine development and manufacturing efforts around the globe.

Speaker: Dr. Erica Dawson, CTO at InDevR
Bio: Dr. Dawson earned her Ph.D. in Analytical Chemistry from The University of North Carolina at Chapel Hill, holds a B.S. from Hartwick College in Oneonta, NY, and completed her postdoctoral training at the University of Colorado at Boulder. Erica has published a wide number of high impact scientific publications and is a named inventor on numerous issued or pending US and worldwide patents. She has been integral in leading the research and development and transfer to manufacturing of InDevR products since 2006.
edtenent_headshot.jpg